戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 etic foot and 155 patients with T2DN without diabetic foot.
2 were high in type 2 diabetic neuropathy with diabetic foot.
3  Neuropathy (T2DN) patients with and without diabetic foot.
4 ntuated in the presence of neuropathy in the diabetic foot.
5 found in patients with T2DN with and without diabetic foot.
6 HbA1c in patients with T2DN with and without diabetic foot.
7 udy comprised of 120 patients with T2DN with diabetic foot and 155 patients with T2DN without diabeti
8 between diabetic neuropathy with and without diabetic foot and periodontitis remains unaddressed in t
9 nopathy, nephropathy, peripheral neuropathy, diabetic foot, and ischemic heart disease were 21.9%, 17
10 he large vessels and microcirculation of the diabetic foot are important in the development of foot u
11 s useful in planning surgery of the infected diabetic foot, as it enables reliable distinction betwee
12    Specific recommendations and pathways for diabetic foot care have been devised.
13                       Microvascular disease, diabetic foot, cerebrovascular disease, cardiovascular d
14  (Explorer) in 43 hospitals with specialised diabetic foot clinics in France, Spain, Italy, Germany,
15 ber 2019, we recruited 305 patients from two diabetic foot clinics.
16 tober 2019, we recruited 305 patients from 2 diabetic foot clinics.
17 c ends, improved prevention and treatment of diabetic foot complications will be necessary to maintai
18  a diabetes diagnosis, were at high risk for diabetic foot complications, were ambulatory, had both f
19 tween DR and VTDR with duration of diabetes, diabetic foot, diabetic neuropathy, agriculture occupati
20       When assessing the economic effects of diabetic foot disease, it is important to remember that
21 olism of the lower extremity were factors in diabetic foot disease.
22 words "probe to bone," "osteomyelitis," and "diabetic foot" from 1946 to May 2015.
23 is, PISA, and clinical AL were higher in the diabetic foot group.
24 nfectious Diseases Society of America (IDSA) diabetic foot infection classification by adding a separ
25  critical limb threatening ischemia(CLTI) or diabetic foot infection(DFI).
26 andscapes of bacterial strains isolated from diabetic foot infections (DFI).
27                                              Diabetic foot infections (DFIs) typically begin in a wou
28 ctam for the treatment of moderate-to-severe diabetic foot infections (DFIs), we obtained 454 pretrea
29                                              Diabetic foot infections are a common and serious proble
30                                              Diabetic foot infections are a leading cause of lower ex
31                                              Diabetic foot infections cause substantial morbidity and
32 nd pitfalls related to infected hardware and diabetic foot infections, and briefly review standards o
33 , that is absent from invasive isolates from diabetic foot infections, including osteomyelitis.
34 nto the lipidomic adaptations of bacteria in diabetic foot infections, thereby laying the groundwork
35 ould be considered for parenteral therapy of diabetic foot infections, when deemed appropriate.
36                Impaired wound healing in the diabetic foot is a major problem often leading to amputa
37 ude that the PTB test can accurately rule in diabetic foot OM in the high-risk patients and rule out
38 iew the accuracy of the PTB test to diagnose diabetic foot OM.
39                             In patients with diabetic foot osteomyelitis (DFO) who underwent surgical
40                             In patients with diabetic foot osteomyelitis (DFO) who underwent surgical
41 e standard for guiding antibiotic therapy in diabetic foot osteomyelitis (DFO).
42 ful response to surgery for the treatment of diabetic foot osteomyelitis are lacking.
43 f ten consecutive patients hospitalized with diabetic foot osteomyelitis who underwent surgery for os
44                 In a cohort of patients with diabetic foot osteomyelitis, we tested the feasibility o
45          The incidence of nonhealing wounds (diabetic foot, pressure, venous, and arterial ulcers) is
46                                              Diabetic foot problems are common throughout the world,
47  95% confidence interval -45.5 to -35.0) and diabetic foot screening (-22.8, -33.9 to -11.7).
48                                     Deferred diabetic foot screening and delays in timely care of acu
49 hase (GM3S) expression is increased in human diabetic foot skin, ob/ob and diet-induced obese diabeti
50  chronic wounds i.e. venous leg ulcer (VLU), diabetic foot ulcer (DFU) and pressure ulcer (PRU).
51                                              Diabetic foot ulcer (DFU) infections are challenging.
52                                              Diabetic foot ulcer (DFU) is a problem worldwide, and pr
53 mical and biological properties is vital for diabetic foot ulcer (DFU) treatment.
54 from colonization to invasion is critical in diabetic foot ulcer (DFU).
55  multistate model showed these associations: diabetic foot ulcer and increased minor amputation; veno
56 artery disease (PAD) in diabetes may lead to diabetic foot ulcer and lower-extremities amputation.
57 ow socioeconomic status have higher rates of diabetic foot ulcer and subsequent amputation compared w
58  of diabetic neuropathy patients developed a diabetic foot ulcer by the one-year follow-up.
59                                    Using the Diabetic Foot Ulcer Challenge 2022 test set, when compar
60  reduce intracellular infection by S. aureus diabetic foot ulcer clinical isolate and S. aureus USA30
61 6 million people worldwide are affected by a diabetic foot ulcer each year, including 1.6 million peo
62 h diabetes and a non-infected neuroischaemic diabetic foot ulcer greater than 1 cm(2) and of grade IC
63 oot self-care behavior on the development of diabetic foot ulcer has received little empirical invest
64 helial repair, which contributes to impaired diabetic foot ulcer healing.
65  the demographic variables and the number of diabetic foot ulcer hospitalizations, however, the effec
66 r predictors (neuropathy severity, number of diabetic foot ulcer hospitalizations, insulin treatment,
67       The data on the regional prevalence of diabetic foot ulcer infecting bacteria and their antimic
68                                              Diabetic foot ulcer is a critical complication of diabet
69 5-year mortality rate for individuals with a diabetic foot ulcer is approximately 30%, exceeding 70%
70     We previously showed that aspects of the diabetic foot ulcer microbiota were correlated with poor
71                                              Diabetic foot ulcer microbiota were found to exist in on
72 r findings advocate race as a risk marker of diabetic foot ulcer outcomes, likely reflecting underlyi
73                                The number of diabetic foot ulcer patients is substantially increasing
74                         Importantly, in both diabetic foot ulcer patients, metagenomic sequencing ide
75 er controlling for demographic variables and diabetic foot ulcer predictors (neuropathy severity, num
76 ides important lessons for future studies on diabetic foot ulcer prevention.
77 at significantly predicted the occurrence of diabetic foot ulcer, even after controlling for demograp
78                           Differentiation of diabetic foot ulcer-derived induced pluripotent stem cel
79  adult Medicare patients hospitalized with a diabetic foot ulcer.
80  behavior as it relates to the occurrence of diabetic foot ulcer.
81 be insufficient to prevent the occurrence of diabetic foot ulcer.
82 pathophysiological deficit in the nonhealing diabetic foot ulcer.
83 ant in wound healing deficiency, typified by diabetic foot ulcer.
84                                              Diabetic foot ulceration (DFU) is a devastating complica
85 is a risk factor for cardiovascular disease, diabetic foot ulceration (DFU), and amputation in diabet
86               PAD is a major risk factor for diabetic foot ulceration and amputation.
87 improve the management of conditions such as diabetic foot ulceration and heel pain syndrome.
88                                              Diabetic foot ulceration is a major complication of diab
89                                              Diabetic foot ulceration is a major diabetic complicatio
90                                              Diabetic foot ulceration is a severe complication of dia
91 n and axon-reflex vasodilation contribute to diabetic foot ulceration, early and prolonged NGF treatm
92 ency department visit or hospitalization for diabetic foot ulceration, osteomyelitis, or gangrene; lo
93 s viewed as beneficial for the prevention of diabetic foot ulceration, the effect of foot self-care b
94 lar, and biomechanical factors contribute to diabetic foot ulceration.
95 on as a potentially successful treatment for diabetic foot ulceration.
96                                              Diabetic foot ulcerations (DFUs) represent a major medic
97                             Most wounds were diabetic foot ulcers (19.0%), venous leg ulcers (26.1%),
98 ospective study of patients with neuropathic diabetic foot ulcers (DFU).
99 e provided insights for reducing the risk of diabetic foot ulcers (DFU).
100                                              Diabetic foot ulcers (DFUs) and subsequent amputation in
101 increasing over time, fueling an epidemic of diabetic foot ulcers (DFUs) and subsequent risk of leg a
102                                   Nonhealing diabetic foot ulcers (DFUs) are a common and costly comp
103                                              Diabetic foot ulcers (DFUs) are a common complication of
104                                              Diabetic foot ulcers (DFUs) are a debilitating complicat
105                                              Diabetic foot ulcers (DFUs) are a leading cause of high
106                                              Diabetic foot ulcers (DFUs) are a life-threatening disea
107                                              Diabetic foot ulcers (DFUs) are a major complication of
108                                              Diabetic foot ulcers (DFUs) are a severe complication of
109                                   Nonhealing diabetic foot ulcers (DFUs) are characterized by low-gra
110 impact of air insole on reducing the risk of diabetic foot ulcers (DFUs) in healthy individuals throu
111  of c-myc, the epidermis surrounding chronic diabetic foot ulcers (DFUs) is clinically hypertrophic a
112                                              Diabetic foot ulcers (DFUs) represent a clinically burde
113                                              Diabetic foot ulcers (DFUs) threaten limbs and prompt ho
114                                              Diabetic foot ulcers (DFUs), a leading cause of amputati
115 he pathophysiology and optimal management of diabetic foot ulcers (DFUs), a leading complication asso
116                                              Diabetic foot ulcers (DFUs), a life-threatening complica
117     Chronic, nonhealing skin wounds, such as diabetic foot ulcers (DFUs), are common in patients with
118 ved inflammation are hallmarks of nonhealing diabetic foot ulcers (DFUs).
119 e suggest its potential role in treatment of diabetic foot ulcers (DFUs).
120 a therapeutic approach for the management of diabetic foot ulcers (DFUs).
121 ined the effect of NETosis on the healing of diabetic foot ulcers (DFUs).
122 onizing potential of S. aureus isolated from diabetic foot ulcers (DFUs).
123 ation in the development and failure to heal diabetic foot ulcers (DFUs).
124                                              Diabetic foot ulcers affect approximately 18.6 million p
125                        Because patients with diabetic foot ulcers and impaired wound healing have red
126                     Advanced DPN can lead to diabetic foot ulcers and non-healing wounds that often n
127                                              Diabetic foot ulcers and other chronic wounds with impai
128 mal precursors-based therapies of nonhealing diabetic foot ulcers and other pathologies with impaired
129 5) may decrease amputations in patients with diabetic foot ulcers and possibly accelerate closure of
130  Similar to chronic wounds on earth, such as diabetic foot ulcers and venous leg ulcers, wounds infli
131                                              Diabetic foot ulcers are serious and challenging wounds
132                                              Diabetic foot ulcers are severe diabetic complications,
133                                              Diabetic foot ulcers have been neglected in health-care
134                  Approximately 30% to 40% of diabetic foot ulcers heal at 12 weeks, and recurrence af
135 e therapeutic potential for the treatment of diabetic foot ulcers if it is applied topically after th
136 able therapeutic option for the treatment of diabetic foot ulcers if it is applied topically after th
137 pplying behavior predicted the occurrence of diabetic foot ulcers in diabetic patients with neuropath
138 t >50% of S. aureus isolates from uninfected diabetic foot ulcers in French patients harbor a prophag
139 ntimicrobial resistance patterns of infected diabetic foot ulcers in sub-Saharan Africa.
140  gram-negative bacteria were associated with diabetic foot ulcers in sub-Saharan Africa.
141           The mortality rate for people with diabetic foot ulcers is 231 deaths per 1000 person-years
142 f the feet, and while its pathogenic role in diabetic foot ulcers is difficult to establish, it may b
143                        Treatment for chronic diabetic foot ulcers is limited by the inability to simu
144                                              Diabetic foot ulcers represent a significant source of m
145 arison with single-cell data from venous and diabetic foot ulcers uncovers a link between failed kera
146 wound swabs from ten patients diagnosed with diabetic foot ulcers were collected and 32 clinical stra
147        Our findings demonstrate that healing diabetic foot ulcers were significantly enriched with di
148 tly improved wound closure of neuroischaemic diabetic foot ulcers without affecting safety after 20 w
149 and the "role of pressure in pathogenesis of diabetic foot ulcers".
150 mporal dynamics of the microbiota colonizing diabetic foot ulcers, a common and costly complication o
151 ections occur in various contexts, including diabetic foot ulcers, burns, and surgical sites.
152 AD) which increases the chance of developing diabetic foot ulcers, gangrene and even lower limb amput
153  studies in the prevention and management of diabetic foot ulcers, including studies that focus on of
154 ail to heal in a timely manner, for example, diabetic foot ulcers, pose a health, economic, and socia
155 zer of skin and as a possible participant in diabetic foot ulcers, we used a selective medium to cult
156 ally new and effective treatment for chronic diabetic foot ulcers.
157 g amputation and mortality for patients with diabetic foot ulcers.
158 reased in nonhealing, compared with healing, diabetic foot ulcers.
159 major (above-ankle) leg amputations owing to diabetic foot ulcers.
160  foot infection are first-line therapies for diabetic foot ulcers.
161 sciplinary care are first-line therapies for diabetic foot ulcers.
162 dation for local galectin-3 therapy to treat diabetic foot ulcers.
163 f antibiotic-resistant clinical strains from diabetic foot ulcers.
164 ions such as lumbar degenerative disease and diabetic foot ulcers.
165 ound closure in patients with neuroischaemic diabetic foot ulcers.
166 sing as a local treatment for neuroischaemic diabetic foot ulcers.
167 rains are maintained in a commensal state in diabetic foot ulcers.
168 cal need to develop therapies for nonhealing diabetic foot ulcers.
169 titis in patients with T2DN with and without diabetic foot was 91.7% and 88.4%, respectively.
170                         Interestingly, human diabetic foot wounds upregulate mRNAs for efferocytosis
171 e a safe and effective treatment for complex diabetic foot wounds, and could lead to a higher proport
172                                              Diabetic foot wounds, particularly those secondary to am

 
Page Top